Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32366580

10 results
Filters applied: . Clear all
Page 1
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, Røsjø H, Dalgard O. Lyngbakken MN, et al. Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0. Trials. 2020. PMID: 32503662 Free PMC article.
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C, Ruiz-Castillo P, Richardson MA, Moncunill G, Casellas A, Carmona-Torre F, Giráldez M, Mota JS, Yuste JR, Azanza JR, Fernández M, Reina G, Dobaño C, Brew J, Sadaba B, Hammann F, Rabinovich R. Chaccour C, et al. Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z. Trials. 2020. PMID: 32513289 Free PMC article.
Canadian Public Health Laboratory Network Best Practices for COVID-19.
Respiratory Virus Infections Working Group1. Respiratory Virus Infections Working Group1. Can Commun Dis Rep. 2020 May 7;46(5):112-118. doi: 10.14745/ccdr.v46i05a02. eCollection 2020 May 7. Can Commun Dis Rep. 2020. PMID: 32558815 Free PMC article.